Caneris Thomas A
EVP, HR and General Counsel at LYTS; SVP, GC and Secretary at PharMerica CORP
- Sold, on record
- $5.4M
- Dollars the filings state
- Form 4 sales
- 14
- Latest Aug 26, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- LYTSLSI INDUSTRIES INCEVP, HR and General Counsel
- PharMerica CORPSVP, GC and Secretary
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- LYTS172,749 shares
- PharMerica CORP59,849 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LYTSNo planAug 22, 2023 2023
Sold 4,485 shares at $15.96 ($72k)
Caneris Thomas A, Exec. VP, HR & General Counsel
No 10b5-1 planSold 8.6% of holdings ($835k position)47,820 shares leftFirst sale on recordFiling
- 2 Form 4 sale LYTSNo planAug 24, 2023 +2 days
Sold 5,909 shares at $15.72 ($93k)
Caneris Thomas A, Exec. VP, HR & General Counsel
No 10b5-1 planSold 12.4% of holdings ($752k position)41,911 shares leftFiling
- 3 Form 4 sale LYTSNo planAug 20, 2024 +362 days
Sold 18,693 shares at $14.41 ($269k)
Caneris Thomas A, Exec. VP, HR & General Counsel
No 10b5-1 planSold 17.2% of holdings ($1.6M position)89,711 shares leftFiling
- 4 Form 4 sale LYTSNo planAug 26, 2025 +371 days
Sold 12,688 shares at $22.98 ($292k)
Caneris Thomas A, Exec. VP, HR & General Counsel
No 10b5-1 planSold 9.4% of holdings ($3.1M position)121,864 shares leftFiling
- 5 Form 4 sale LYTSNo planAug 27, 2025 +1 day
Sold 7,544 shares at $23.08 ($174k)
Caneris Thomas A, Exec. VP, HR & General Counsel
No 10b5-1 planSold 6.2% of holdings ($2.8M position)114,016 shares leftFiling
- 6 Form 4 sale LYTSUnusualMay 28, 2026 +274 days
Sold 109,226 shares at $24.29 ($2.7M)
Caneris Thomas A, EVP, HR and General Counsel
No 10b5-1 planSold 62.8% of holdings ($4.2M position)64,790 shares left8.6x usual sizeFiling
- 7 Form 4 sale LYTSNo planAug 25, 2026 +89 days
Sold 11,034 shares at $19.94 ($220k)
Caneris Thomas A, EVP, HR and General Counsel
No 10b5-1 planSold 12.6% of holdings ($1.7M position)76,279 shares left0.9x usual sizeFiling
- 8 Form 4 sale LYTSNo planAug 26, 2026 +1 day
Sold 3,170 shares at $20.28 ($64k)
Caneris Thomas A, EVP, HR and General Counsel
No 10b5-1 planSold 4.2% of holdings ($1.5M position)73,109 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Aug 27, 2026 | LYTS | EVP, HR and General Counsel | Form 4 sale | 3,170 | $64k | 4.2% | No plan | SEC |
| Aug 25, 2026 | Aug 26, 2026 | LYTS | EVP, HR and General Counsel | Form 4 sale | 11,034 | $220k | 12.6% | No plan | SEC |
| May 28, 2026 | Jun 1, 2026 | LYTS | EVP, HR and General Counsel | Form 4 sale | 109,226 | $2.7M | 62.8% | Unusual | SEC |
| Aug 27, 2025 | Aug 29, 2025 | LYTS | Exec. VP, HR & General Counsel | Form 4 sale | 7,544 | $174k | 6.2% | No plan | SEC |
| Aug 26, 2025 | Aug 27, 2025 | LYTS | Exec. VP, HR & General Counsel | Form 4 sale | 12,688 | $292k | 9.4% | No plan | SEC |
| Aug 20, 2024 | Aug 21, 2024 | LYTS | Exec. VP, HR & General Counsel | Form 4 sale | 18,693 | $269k | 17.2% | No plan | SEC |
| Aug 24, 2023 | Aug 28, 2023 | LYTS | Exec. VP, HR & General Counsel | Form 4 sale | 5,909 | $93k | 12.4% | No plan | SEC |
| Aug 22, 2023 | Aug 24, 2023 | LYTS | Exec. VP, HR & General Counsel | Form 4 sale | 4,485 | $72k | 8.6% | No plan | SEC |
| May 12, 2015 | May 14, 2015 | PharMerica CORP | SVP, GC and Secretary | Form 4 sale | 7,052 | $212k | 9.4% | Plan not stated | SEC |
| Mar 12, 2015 | Mar 13, 2015 | PharMerica CORP | SVP, GC and Secretary | Form 4 sale | 7,495 | $199k | 11.2% | Plan not stated | SEC |
| Mar 5, 2015 | Mar 6, 2015 | PharMerica CORP | SVP, GC and Secretary | Form 4 sale | 17,253 | $466k | 20.2% | Plan not stated | SEC |
| May 13, 2014 | May 13, 2014 | PharMerica CORP | SVP, GC and Secretary | Form 4 sale | 12,192 | $349k | 13.9% | Plan not stated | SEC |
| Mar 6, 2014 | Mar 7, 2014 | PharMerica CORP | SVP, GC and Secretary | Form 4 sale | 14,357 | $367k | 20.1% | Plan not stated | SEC |
| Dec 2, 2010 | Dec 6, 2010 | PharMerica CORP | SVP, GC and Secretary | Form 4 sale | 1,500 | $17k | 9.1% | Plan not stated | SEC |